Onvansertib effectively targets the once “undruggable” KRAS-mutation present in 50% of colorectal cancerNew Podcast

Investor Relations

News and Events

H.C. Wainwright 23rd Annual Global Investment Conference

Cardiff Oncology Chief Executive Officer, Dr. Mark Erlander, and Chief Financial Officer, James Levine will participate in the H.C. Wainwright Investment Conference September 13th - 15th, 2021. The Company presentation can be accessed on demand at: https://journey.ct.events/view/50ff15c3-cb28-455a-bf01-6e3b2c0dcfce